Related Experiment Video
Updated: May 16, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
The global perspective on irritable bowel syndrome: a Rome Foundation-World Gastroenterology Organisation symposium
Ami D Sperber1, Douglas A Drossman, Eamonn M M Quigley
1Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel. amiroie@me.com
Abstract:
Although irritable bowel syndrome (IBS) is common worldwide, there is uncertainty regarding similarities and differences in geographical regions and cultural groups. For example, are Western diagnostic criteria applicable to other groups? The interaction between culture and health can impact quality of care and health outcomes and, in research, cause methodological shortcomings that lead to bias and inappropriate interpretations of research results. Two central questions are: do physicians have the cross-cultural competence to effect a participatory model of care; and do we have sufficient knowledge and experience in conducting multinational, cross-cultural research? The Rome Foundation and the World Gastroenterology Organisation convened a symposium to foster interest in the global aspects of IBS, foster cross-cultural competence, improve multinational IBS research, foster international networks for IBS research, increase awareness of culture's impact on patient care and research in the functional gastrointestinal disorders (FGIDs), address cross-cultural issues in multinational clinical drug trials, and facilitate the development of patient-reported outcome measures for FGID research across cultures. This review summarizes key points and messages.
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
